
VALANX Biotech, a company developing novel technology for site-specific protein conjugation in drug discovery, has appointed Klause Orlinger as Chief …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

